$BMSN I'm with you on that, Sizzle. This is going to be a big year for cancer therapeutics. The gatekeeper has now changed sides to that of the patient vs that of the regulator. Couple that with N.I.H.'s added $2B budget specifically for cancer research, and we're off to the races. Hoping for news this week as well!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.